HAFC vs MRNA · P/E 11, rev $143.9M vs rev $145.0M
Hanmi Financial Corporation (HAFC) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Hanmi Financial Corporation (HAFC) is a banks - regional company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported HAFC revenue for 2026-06-30 was $143.9M. Net income was $46.1M. HAFC currently screens at market cap $905.8M and trailing P/E 11.4.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
HAFC currently screens at market cap $905.8M and trailing P/E 11.4. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the HAFC and MRNA stock pages for the full models.
Not investment advice.